Left ventricular assist device and drug therapy for the reversal of heart failure - Wikidata - awgldk - TriplyDB

Left ventricular assist device and drug therapy for the reversal of heart failure

Left ventricular assist device and drug therapy for the reversal of heart failure

http://www.wikidata.org/entity/Q28271792

about

Devices in the management of advanced, chronic heart failure Cardiac CT: Imaging of and Through Cardiac Devices.Continuous internal counterpulsation as a bridge to recovery in acute and chronic heart failure Mechanical Ventricular Assistance as Destination Therapy for End-Stage Heart Failure: Has it Become a First Line Therapy?Why pulsatility still matters: a review of current knowledge Left ventricular assist devices as a bridge to cardiac transplantation.Ventricular assist devices: pharmacological aspects of a mechanical therapy Ventricular arrhythmias in patients with implanted ventricular assist devices: a contemporary review A Development of Nucleic Chromatin Measurements as a New Prognostic Marker for Severe Chronic Heart Failure Adult cardiac progenitor cell aggregates exhibit survival benefit both in vitro and in vivo Bridge to removal: a paradigm shift for left ventricular assist device therapy.Mechanical Circulatory Support for the Failing Heart: Continuous-Flow Left Ventricular Assist Devices.Rat Heterotopic Heart Transplantation Model to Investigate Unloading-Induced Myocardial Remodeling S100A1 in human heart failure: lack of recovery following left ventricular assist device support Left ventricular assist devices: current controversies and future directions.The Cohn felt plug: an effective HeartMate II® reimplantation technique.G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.Partial LVAD restores ventricular outputs and normalizes LV but not RV stress distributions in the acutely failing heart in silico.Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure.Mechanical circulatory support: a clinical reality.Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure Left ventricular remodeling and myocardial recovery on mechanical circulatory support.Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy.Myostatin activation in patients with advanced heart failure and after mechanical unloading.Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation.Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung, and Blood Institute.β-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades.Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface.Medical management of patients with continuous-flow left ventricular assist devices.Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading.Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices Bovine model of doxorubicin-induced cardiomyopathy Left ventricular assist device outflow graft: alternative sites.Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading.Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart.Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices.Pediatric heart failure: current state and future possibilities.Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling.

P2860

Q24630052-7333F508-2AF0-46C2-B32E-56A2A7B31B09 Q24631157-353B1AB3-B68E-4320-9C4C-248E912106EF Q26751457-FD48A9FC-2B15-4A9F-9A3A-99471EAAB4DC Q26797254-BFA0811F-A870-4F3D-B711-6B7DD65FA305 Q26864718-6CE481C8-2701-46BE-8101-8C73A3A1A2C5 Q26999337-8A320AAB-E9F0-47C8-B615-D6D5D5B86D48 Q27002612-A9CEB0E4-7C85-4FD7-8BFF-E2BB59FC5A5E Q27026786-AAEA3912-29F5-4B8E-93DB-62B8C84CACA1 Q27324154-541C3B96-D164-401B-84EA-725474AC70EA Q27334044-DF010607-978D-4893-B3EF-A02646422F15 Q27691340-02A43ACD-CE5E-4A00-8C05-344EA01E60FC Q28071544-54A1FDBF-38F6-4168-9C93-520D74DA29A4 Q28078529-1A27D843-D31B-4A79-ADC7-ABEA8A59FE25 Q28240412-033533E5-5CF4-494D-81F1-EECD05DDC60C Q30252054-DC4A42A9-F381-4F5E-B10B-38467873C4FA Q30455085-756276A9-64E7-41D2-A833-2ED695EDEB46 Q30487539-31D48855-9356-4AA7-9ADC-EABE0BCE3242 Q30823346-E44B4E6A-1EF9-4468-AB7F-0D811FFDD5F1 Q33163104-36778020-56CC-41C2-BE32-68A736BF0CB5 Q33371447-7E18D292-01F5-44FB-AC0C-6494304F04FE Q33555629-8B33F84C-95BD-4B22-ABED-CA240E0D4ABC Q33645107-AB0A0DD3-0F26-430D-ABD3-A395ED4A8337 Q33651722-28F5E3A7-D3FB-4832-B6B0-A2F9C330CBD1 Q33703889-44DB146A-5475-48A5-8C1C-71061A53AF38 Q33789760-77C41F2D-3470-4CD5-80A4-5E7C28072BC5 Q33803837-D1FB7E2C-7496-4BD2-82BE-929D535BE764 Q33818507-F571CF6A-E4E5-412F-84AD-4C041F17896D Q33917995-28B26226-FD7E-4E6C-8AA8-852FE8480E0B Q34058699-147BF121-7FD0-4E36-A493-6D9693986930 Q34072238-A6FCE39D-B905-49DF-AE12-0BB07B31D198 Q34152572-9E2FC65B-46DF-4CA9-B769-AEDEBB098A63 Q34275561-25BE57AB-A155-4B2D-9430-A32A4E45140F Q34412796-FEAA3F5F-22A9-411E-BB19-3C2CFB5165A9 Q34479363-AB650667-D564-46E9-83DC-851D0B8D50B8 Q34498780-1D52F454-EE56-47F8-B413-408EE7503163 Q34548956-7F67E15A-D319-4C40-9796-41C61B2AE437 Q34641010-468C20E6-1E2E-4ECB-B412-E499793C34B3 Q34916572-9AAEE567-435C-49F5-ACF5-45AC81AA6F7A Q35028584-07CDE7B4-8EA8-45AC-A9C2-0E2150C5A1BC Q35228339-A59D1123-68FC-47A7-8A5D-213F73579321

P2860

Left ventricular assist device and drug therapy for the reversal of heart failure

http://www.wikidata.org/entity/Q28271792

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Left ventricular assist device and drug therapy for the reversal of heart failure

@ast

Left ventricular assist device and drug therapy for the reversal of heart failure

@en

Left ventricular assist device and drug therapy for the reversal of heart failure

@nl

type

label

Left ventricular assist device and drug therapy for the reversal of heart failure

@ast

Left ventricular assist device and drug therapy for the reversal of heart failure

@en

Left ventricular assist device and drug therapy for the reversal of heart failure

@nl

prefLabel

Left ventricular assist device and drug therapy for the reversal of heart failure

@ast

Left ventricular assist device and drug therapy for the reversal of heart failure

@en

Left ventricular assist device and drug therapy for the reversal of heart failure

@nl

P1433

Q28271792-FAA9EB70-9F75-4815-A115-2B2D5F8DF330

P1476

Q28271792-017C2477-2F90-4F83-8593-971D913640F3

P2093

Q28271792-434F78CC-86F5-4865-85F9-616964B1BA95

Q28271792-474FA65E-E120-440C-94AE-5CCC5F276F81

Q28271792-5D452518-2EB1-4058-A1A1-3ABEFA2375DD

Q28271792-A807F8D1-6EF8-4603-BCE4-1D4DF3707BA0

Q28271792-B299A559-5C29-43F7-9B06-6EC2126C48A4

Q28271792-BF96CC89-C016-426D-A6E7-418DA9E3BB9A

Q28271792-D2C79294-1C71-4233-A333-24796E2EC7CB

Q28271792-FB92F6CF-2CD9-4BB5-AA04-76A56AEADB62

P304

Q28271792-23E1A630-BBD7-47E6-B1E1-C3DF68965393

P31

Q28271792-6147602C-F4D3-4799-9C2F-BEF9EED99A1A

P3181

Q28271792-D79EA557-43E4-429F-9EFB-6863BCCFE691

P356

Q28271792-67121C0F-73EF-49BF-B6B5-BE6DF32D7A20

P407

Q28271792-692048C6-BDA3-4096-9DEA-8AA82649C4AB

P433

Q28271792-E271A8A1-89C3-4064-B4D0-250EE77B7F1E

P478

Q28271792-97D1CF39-8C88-45DB-8F0B-A7892B6D1288

P50

Q28271792-8695B650-ED2A-40A8-889C-94D4A958791C

P577

Q28271792-73A80AB5-C34D-43CD-9F1F-CA8D6A0F071A

P698

Q28271792-08937803-A846-4239-BB36-4BC100F0021F

P921

Q28271792-BE599416-0F14-4886-9ED9-EC9EC38DD19C

P3181

P356

P1433

The New England Journal of Medicine

P1476

Left ventricular assist device and drug therapy for the reversal of heart failure

@en

P2093

Asghar Khaghani

http://www.w3.org/2001/XMLSchema#string

Christopher T Bowles

http://www.w3.org/2001/XMLSchema#string

Emma J Birks

http://www.w3.org/2001/XMLSchema#string

James Hardy

http://www.w3.org/2001/XMLSchema#string

Magdi H Yacoub

http://www.w3.org/2001/XMLSchema#string

Margaret Burke

http://www.w3.org/2001/XMLSchema#string

Nicholas R Banner

http://www.w3.org/2001/XMLSchema#string

Patrick D Tansley

http://www.w3.org/2001/XMLSchema#string

P304

1873-1884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

342813

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA053063

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

355

http://www.w3.org/2001/XMLSchema#string

P50

Robert S George

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17079761

http://www.w3.org/2001/XMLSchema#string

P921